796 – Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single-Dose Study
Background Physiologic changes that occur during pregnancy can significantly alter the pharmacokinetics (PK) of antiretrovirals (ARV), potentially impacting maternal HIV suppression and vertical transmission risk. Doravirine (DOR), a once-daily potent NNRTI with a strong safety profile, could be used during pregnancy if data were available to optimize dosing strategies during gestation and post-partum. Methods…